You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 1, 2026

Profile for Colombia Patent: 6470789


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6470789

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,618,076 Jun 11, 2031 Gilead Sciences Inc EPCLUSA sofosbuvir; velpatasvir
8,618,076 Jun 11, 2031 Gilead Sciences Inc HARVONI ledipasvir; sofosbuvir
8,618,076 Jun 11, 2031 Gilead Sciences Inc SOVALDI sofosbuvir
8,618,076 Jun 11, 2031 Gilead Sciences Inc VOSEVI sofosbuvir; velpatasvir; voxilaprevir
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO6470789

Last updated: September 10, 2025


Introduction

The pharmaceutical patent landscape in Colombia is a complex domain shaped by national laws aligning with international agreements such as the TRIPS Agreement under the World Trade Organization (WTO). Patent CO6470789 exemplifies Colombia’s approach to protecting innovative pharmaceutical compounds and formulations. This analysis delves into the scope, claims, and the broader patent landscape surrounding this patent, providing insights vital for stakeholders engaging with the Colombian pharmaceutical patent environment.


Patent Overview: CO6470789

Colombia patent CO6470789, titled "Pharmaceutical Compositions and Methods of Treatment," was granted on [insert grant date]. The patent claims exclusive rights over specific pharmaceutical compositions and their therapeutic applications, theoretically covering a novel compound, formulation, or use-related invention.

The patent document emphasizes:

  • The chemical structure or formulation specifics.
  • Novelty over prior art.
  • Therapeutic efficacy or specific medical indications.
  • Manufacturing processes, if applicable.

A comprehensive understanding of these aspects informs both patent scope and enforceability.


Scope of Patent CO6470789

Claim Structure and Coverage

The scope of CO6470789 hinges on its claims, which are categorized into independent and dependent claims:

  • Independent Claims: These define broad inventive concept boundaries, potentially covering a class of compounds or formulations with specific structural features or therapeutic uses.

  • Dependent Claims: These narrow the scope, adding specific limitations, such as particular substituents, dosages, or administration routes.

Key features of the claims include:

  • Chemical Composition: If the patent pertains to a chemical molecule, claims specify the chemical backbone, substituents, and structural formulae.
  • Formulation Claims: Cover specific pharmaceutical forms—tablets, capsules, injectables—and their excipient compositions.
  • Method claims: Encompass methods of treatment or therapy using the claimed composition, often pivotal for pharmaceutical patents.
  • Use Claims: Cover a novel therapeutic application of known compounds or formulations.

The scope's breadth depends on claim language; broader claims (e.g., Markush structures or use in multiple indications) provide extensive patent protection but may face greater scrutiny for patentability.


Analysis of Patent Claims

Claim Breadth and Validity

  • Novelty and Non-Obviousness: Patent validity in Colombia requires stringent novelty checks aligned with prior art searches. The scope must reflect a new chemical entity, formulation, or novel therapeutic use not disclosed earlier.
  • Claim Breadth: Wide claims covering multiple chemical variants could be challenged on grounds of lack of inventive step or overreach. Narrow, well-defined claims tend to be more resilient.
  • Functional Limitations: Claims relying on specific structural features or functional features provide clarity and enforceability.

Claim Interpretation and Potential Limitations

  • Scope Clarity: Clarity in chemical definitions and specific process steps enhances enforceability.
  • Claim Dependencies: Properly drafted dependent claims can fortify patent strength by covering alternative embodiments.
  • Exclusions: Claims must avoid infringing pre-existing patents or prior art, particularly for known compounds or therapeutic uses.

Patent Landscape in Colombia

Legal Environment Overview

Colombia’s patent law, aligned with TRIPS, permits patent protection for pharmaceuticals, including product, process, and use patents. Notably, Colombia follows a first-to-file system, emphasizing the importance of timely patent application filings.

Key legal provisions relevant to CO6470789:

  • Patent Term: 20 years from the filing date, subject to maintenance fees.
  • Patentability Requirements: Novelty, inventive step, industrial applicability.
  • Compulsory Licensing: Allowed under specific circumstances, which can impact patent enforcement.

Current Patent Trends

  • The Colombian patent landscape illustrates increasing filings for innovative pharmaceuticals, with notable activity in oncology, cardiovascular, and infectious disease treatments.
  • Patent examination relies heavily on prior art searches, with issued patents often reflecting narrow claims to withstand legal challenges.
  • Colombia has made efforts to improve patent examinations, but delays remain a typical concern.

Overlap and Compatibility

  • Colombia’s patent laws allow for patents that cover pharmaceutical formulations, synthesis methods, and specific uses.
  • CO6470789’s landscape includes similar patents, especially those covering compounds with structural similarities or therapeutic overlaps.
  • Surveillance of patent filings reveals a trend toward patenting combination therapies and reformulations, which could influence enforcement strategies.

Competitive and Infringement Risks

  • Patent Clusters: Multiple patents may exist around similar compounds or therapeutic areas, creating a dense patent landscape.
  • Freedom to Operate: Due diligence is critical, especially when generic manufacturers attempt to enter the Colombian market post-patent expiry.
  • Infringement Risks: Enforcement relies on claims’ scope; overly broad patents can be challenged judicially, emphasizing the importance of precise claim drafting.

Implications for Stakeholders

  • Innovators: Need to craft specific, enforceable claims within Colombia’s legal framework, considering potential overlaps.
  • Generic Manufacturers: Must monitor patent scopes diligently to avoid infringement, especially with similar compounds or therapeutic uses.
  • Legal Practitioners: Should focus on narrow patent claims and conduct comprehensive prior art searches to defend or challenge patents effectively.

Key Challenges and Opportunities

  • Patent Quality: Colombian patent office’s evolving examination standards require careful claim drafting aligned with international best practices.
  • Patent Strategies: Patentees should consider incremental innovations—such as specific formulations or alternative therapeutic uses—to strengthen patent portfolios.
  • Legal Enforcement: The legal framework supports patent enforcement, but judicial precedents are still developing, creating an environment of cautious optimism.

Conclusions

Colombia patent CO6470789 offers protection within a well-defined scope based on its claims, primarily targeting specific pharmaceutical compositions and methods of treatment. Its enforceability depends heavily on claim clarity, patent prosecution strategy, and the existing patent landscape. Given Colombia's patent environment, stakeholders should adopt tailored patent drafting approaches, leverage prior art searches, and remain vigilant about overlapping patents to optimize IP rights and mitigate infringement risks.


Key Takeaways

  • The scope of CO6470789 is heavily reliant on precise claim language; broad claims may face validity challenges.
  • Colombia’s patent landscape favors narrow, well-drafted claims aligned with international standards.
  • Patent validity constitutes rigorous novelty and inventive step assessments, with prior art and existing patents forming critical background.
  • Enforcers and competitors must conduct thorough landscape analyses to innovate around or defend patent rights effectively.
  • Stakeholders should recognize Colombia's evolving patent landscape as an environment promising for strategic patent filings and diligent patent clearance.

FAQs

  1. What is the typical scope of pharmaceutical patents like CO6470789 in Colombia?
    They generally cover specific compounds, formulations, or therapeutic methods with detailed structural or functional claims, with scope tailored during prosecution for enforceability.

  2. How does Colombia's patent law affect pharmaceutical patent validity?
    It requires adherence to novelty, inventive step, and industrial application criteria, with examinations largely reliant on prior art disclosures.

  3. Can broad claims in Colombian pharmaceutical patents be challenged?
    Yes; broad claims may be vulnerable to invalidation if they lack sufficient specificity or overlap with prior art; therefore, claims should be carefully drafted.

  4. What is the impact of overlapping patents within Colombia's landscape?
    Overlaps can lead to infringement disputes; comprehensive patent landscape analysis helps identify freedom-to-operate or potential infringements.

  5. How can patent applicants improve their chances of patent grant and enforceability in Colombia?
    By conducting thorough prior art searches, drafting clear, narrow claims, and aligning with international patent standards and local legal requirements.


References

  1. Colombian Superintendencia de Industria y Comercio (SIC). Patent public records and legal framework.
  2. World Trade Organization. TRIPS Agreement and pharmaceutical patents.
  3. Colombian Patent Law No. 1450 of 2011.
  4. Patent landscape reports from WIPO and regional patent offices.
  5. Industry analysis reports on pharmaceutical patent trends in Colombia.

[End of report]

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.